Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine Extended-Release in Children With ADHD
NCT01069523Phase 4Completed
- Sponsor
- UT Health San Antonio
- Start
- Mar 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Placebo with Guanfacine Extended Release (2 arms). Primary endpoint: DuPaul ADHD Rating Scale at 4 weeks. Started Mar 2010; status: completed.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01069523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01069523.